RankingsPricing
  1. JP-listed companies
  2. SANTEN PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Stockholders' equity

SANTEN PHARMACEUTICAL CO.,LTD.【JP:4536】

Market cap
¥573.5B
P/E ratio
16.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2025285,181-6.61%
Mar 31, 2024305,369+4.12%
Mar 31, 2023293,297-12.93%
Mar 31, 2022336,844+9.70%
Mar 31, 2021307,050+1.48%
Mar 31, 2020302,560+3.41%
Mar 31, 2019292,572+10.09%
Mar 31, 2018265,765+8.32%
Mar 31, 2017245,358-2.69%
Mar 31, 2016252,151+24.08%
Mar 31, 2015203,211+12.52%
Mar 31, 2014180,598

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)